The Health Ministry in Malaysia welcomes applications to conduct clinical trials on products containing cannabis extract for medical purposes as there are no such trials being carried out at the moment, Deputy Health Minister Dr Noor Azmi said on Thursday (Jul 28) Malaysia’s Dangerous Drugs Act 1952, Poisons Act 1952 and the Sale of Drugs Act 1952 allow for cannabis extract to be supplied, imported, sold and used for medical purposes, research, or clinical trials,…